Literature DB >> 10689131

Diseases of aging.

G Wick1, P Jansen-Dürr, P Berger, I Blasko, B Grubeck-Loebenstein.   

Abstract

By definition, diseases of aging become clinically manifested in elderly patients. However, their pathogenetic basis has to be sought earlier in life. The general thread of this presentation relies on the concept of an evolutionary-Darwinian view of the development of age-related diseases. In essence, this concept states that we may have to "pay" for genetic traits that play a beneficial role earlier in life by the later development of diseases since there is no post-reproductive selective pressure that may have eliminated the potential late onset detrimental effects of such genes. Examples for this kind of trade-off are taken from diseases involving the immune system (infections), the endocrine system (andropause), the nervous system (Alzheimer's disease), the locomoter system (osteoporosis), the cardio-vascular system (atherosclerosis) and cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10689131     DOI: 10.1016/s0264-410x(99)00489-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  30 in total

1.  Nonmalignant clonal expansions of memory CD8+ T cells that arise with age vary in their capacity to mount recall responses to infection.

Authors:  Jacob E Kohlmeier; Lisa M Connor; Alan D Roberts; Tres Cookenham; Kyle Martin; David L Woodland
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

Review 2.  Dysregulation of T-cell function in the elderly : scientific basis and clinical implications.

Authors:  Tamas Fulop; Anis Larbi; Anders Wikby; Eugenio Mocchegiani; Katsuiku Hirokawa; Graham Pawelec
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Aging and CD8+ T cell immunity to respiratory virus infections.

Authors:  Kenneth H Ely; Alan D Roberts; Jacob E Kohlmeier; Marcia A Blackman; David L Woodland
Journal:  Exp Gerontol       Date:  2007-01-02       Impact factor: 4.032

Review 4.  KLRG1--more than a marker for T cell senescence.

Authors:  Sian M Henson; Arne N Akbar
Journal:  Age (Dordr)       Date:  2009-12

5.  What is aging?

Authors:  Beatrix Grubeck-Loebenstein
Journal:  Transfus Med Hemother       Date:  2012-10       Impact factor: 3.747

6.  Towards an Age-Phenome Knowledge-base.

Authors:  Nophar Geifman; Eitan Rubin
Journal:  BMC Bioinformatics       Date:  2011-06-08       Impact factor: 3.169

7.  KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection.

Authors:  Lei Shi; Jia M Wang; Jun P Ren; Yong Q Cheng; Ruo S Ying; Xiao Y Wu; Shu M Lin; Jeddidiah W D Griffin; Guang Y Li; Jonathan P Moorman; Zhi Q Yao
Journal:  J Immunol       Date:  2013-12-13       Impact factor: 5.422

8.  Is the rate of biological aging, as measured by age at diagnosis of cancer, socioeconomically patterned?

Authors:  Jean Adams; Martin White; David Forman
Journal:  J Epidemiol Community Health       Date:  2005-02       Impact factor: 3.710

Review 9.  Managing moderate-to-severe psoriasis in the elderly.

Authors:  Nicola Balato; Cataldo Patruno; Maddalena Napolitano; Angela Patrì; Fabio Ayala; Raffaele Scarpa
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

Review 10.  Immunological outcomes of exercise in older adults.

Authors:  David S Senchina; Marian L Kohut
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.